Christopher Horan - 15 May 2025 Form 4 Insider Report for Artiva Biotherapeutics, Inc. (ARTV)

Role
Chief Tech Operations Officer
Signature
/s/ Neha Krishnamohan, Attorney-in-Fact
Issuer symbol
ARTV
Transactions as of
15 May 2025
Net transactions value
-$12,693
Form type
4
Filing time
18 Aug 2025, 20:15:05 UTC
Previous filing
28 Feb 2025
Next filing
17 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Horan Christopher Chief Tech Operations Officer C/O ARTIVA BIOTHERAPEUTICS, INC., 5505 MOREHOUSE DRIVE, SUITE 100, SAN DIEGO /s/ Neha Krishnamohan, Attorney-in-Fact 18 Aug 2025 0001736819

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARTV Common Stock Tax liability $2,856 -1,341 -1.6% $2.13 83,659 15 May 2025 Direct F1
transaction ARTV Common Stock Tax liability $9,837 -3,577 -4.3% $2.75 80,082 15 Aug 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards.